Education
About Us
Working with TipRanks
Follow Us
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
Total Valuation
Prime Medicine, Inc. has a market cap or net worth of $640.81M. The enterprise value is $794.04M.
Market Cap$640.81M
Enterprise Value$794.04M
Share Statistics
Prime Medicine, Inc. has 180,510,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding180,510,650
Owned by Insiders49.88%
Owned by Institutions0.22%
Financial Efficiency
Prime Medicine, Inc.’s return on equity (ROE) is -1.28 and return on invested capital (ROIC) is -76.94%.
Return on Equity (ROE)-1.28
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-76.94%
Return on Capital Employed (ROCE)-0.78
Revenue Per Employee13.94K
Profits Per Employee-915.34K
Employee Count214
Asset Turnover0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Prime Medicine, Inc. is ―. Prime Medicine, Inc.’s PEG ratio is 0.07.
PE Ratio―
PS Ratio116.10
PB Ratio2.26
Price to Fair Value2.26
Price to FCF-2.66
Price to Operating Cash Flow-5.78
PEG Ratio0.07
Income Statement
In the last 12 months, Prime Medicine, Inc. had revenue of 2.98M and earned -195.88M in profits. Earnings per share was -1.65.
Revenue2.98M
Gross Profit2.98M
Operating Income-202.47M
Pretax Income-195.88M
Net Income-195.88M
EBITDA-196.34M
Earnings Per Share (EPS)-1.65
Cash Flow
In the last 12 months, operating cash flow was -109.06M and capital expenditures -6.03M, giving a free cash flow of -115.09M billion.
Operating Cash Flow-109.06M
Free Cash Flow-115.09M
Free Cash Flow per Share-0.64
Dividends & Yields
Prime Medicine, Inc. pays an annual dividend of $0.8, resulting in a dividend yield of ―
Dividend Per Share$0.8
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.03
52-Week Price Change-0.30%
50-Day Moving Average4.99
200-Day Moving Average3.10
Relative Strength Index (RSI)34.82
Average Volume (3m)4.15M
Important Dates
Prime Medicine, Inc. upcoming earnings date is Feb 27, 2026, Before Open (Confirmed).
Last Earnings DateNov 7, 2025
Next Earnings DateFeb 27, 2026
Ex-Dividend DateSep 10, 2019
Financial Position
Prime Medicine, Inc. as a current ratio of 5.58, with Debt / Equity ratio of 73.00%
Current Ratio5.58
Quick Ratio5.58
Debt to Market Cap0.00
Net Debt to EBITDA0.72
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Prime Medicine, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Prime Medicine, Inc. EV to EBITDA ratio is -1.04, with an EV/FCF ratio of -1.57.
EV to Sales68.60
EV to EBITDA-1.04
EV to Free Cash Flow-1.57
EV to Operating Cash Flow-1.67
Balance Sheet
Prime Medicine, Inc. has $208.43M in cash and marketable securities with $118.14M in debt, giving a net cash position of $90.29M billion.
Cash & Marketable Securities$208.43M
Total Debt$118.14M
Net Cash$90.29M
Net Cash Per Share$0.50
Tangible Book Value Per Share$1.29
Margins
Gross margin is 48.32%, with operating margin of -6787.36%, and net profit margin of -6566.61%.
Gross Margin48.32%
Operating Margin-6787.36%
Pretax Margin-6566.61%
Net Profit Margin-6566.61%
EBITDA Margin-6581.93%
EBIT Margin-6787.36%
Analyst Forecast
The average price target for Prime Medicine, Inc. is $6.08, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.08
Price Target Upside82.58% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast647.13%
EPS Growth Forecast26.79%